Insider Activity of Giordano Christopher Thomas
According to the SEC Form 4 filings, Giordano Christopher Thomas, being in a position of
- CEO at Tenax Therapeutics, Inc.,оver the last 12 months, has bought 13455 shares for $40,087, and sold 0 shares,over all time since 2025-11-18, has bought 13455 shares for $40,087, and sold 0 shares.
Biography of Giordano Christopher Thomas
No biography is available at this moment.